NeuBase Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€29.53M +33.4% N/A -€24.62M +63.7% N/A
    €0.00 +NaN% -€22.14M +48.7% N/A -€15.04M +74.5% N/A
    €0.00 +NaN% -€14.89M -36.3% N/A -€8.62M +335.8% N/A
    €0.00 +NaN% -€23.37M +104.6% N/A -€1.98M -75.8% N/A
    €0.00 +NaN% -€11.42M -44.4% N/A -€8.19M -50.8% N/A
    €0.00 +NaN% -€20.54M -7.6% N/A -€16.64M +20.8% N/A
    €0.00 +NaN% -€22.23M +69.5% N/A -€13.78M +52.0% N/A
    €0.00 +NaN% -€13.11M +66.4% N/A -€9.06M +465.2% N/A
    €0.00 +NaN% -€7.88M +61.5% N/A -€1.60M -30.9% N/A
    €0.00 +NaN% -€4.88M +288.5% N/A -€2.32M +56.3% N/A
    €0.00 +NaN% -€1.25M -71.5% N/A -€1.48M +71.3% N/A
    €0.00 +NaN% -€4.40M -1,131.9% N/A -€866.49K +102.2% N/A
    €0.00 +NaN% €426.44K -157.2% N/A -€428.51K +331.3% N/A
    €0.00 +NaN% -€745.66K -3,557.8% N/A -€99.34K -77.8% N/A
    €0.00 -100.0% €21.56K -100.4% N/A -€447.68K -89.6% N/A
    €335.55K -93.2% -€5.44M -2,311.7% -1,620.6% -16 pp -€4.30M -1,939.6% -1,281.7% -13 pp
    €4.91M +48.3% €245.86K +179.8% 5.0% +0.024 pp €233.79K -5,135.0% 4.8% +0.049 pp
    €3.31M €87.86K 2.7% -€4.64K -0.1%

    Notifications